Insider · CIK 0001373649
Susan Benton
Files at IRD (Opus Genetics, Inc.). First filing -, latest -.
In brief
Susan Benton files SEC Form 4 as director at IRD (Opus Genetics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Susan Benton has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | IRD Opus Genetics, Inc. | AGrant or award Common Stock | +24,367 | $0.00 | $0 | 243,894 | Apr 22, 2026 |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | AGrant or award Common Stock | +79,504 | $0.00 | $0 | 219,527 | May 2, 2025 |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +79,592 | $0.00 | $0 | 79,592 | May 2, 2025 |
Questions about Susan Benton
Answered from the filings on this page, as of the latest one.
Is Susan Benton buying or selling?
Susan Benton has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Susan Benton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Susan Benton has 0.
Where does Susan Benton file Form 4?
Susan Benton has filed Form 4 at IRD (Opus Genetics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.